47 results on '"Morais-Braga MFB"'
Search Results
2. Matricaria genus as a source of antimicrobial agents: From farm to pharmacy and food applications
- Author
-
Jolanta Nazaruk, Giulia Tabanelli, Mehdi Sharifi-Rad, Henrique Douglas Melo Coutinho, Deepa R. Verma, William N. Setzer, Maria Flaviana Bezerra Morais-Braga, Bahare Salehi, Chiara Montanari, Janaína Esmeraldo Rocha, Antoni Sureda, Javad Sharifi-Rad, Miquel Martorell, Letizia Polito, María del Mar Contreras, Zubaida Yousaf, and Sharifi-Rad M, Nazaruk J, Polito L, Morais-Braga MFB, Rocha JE, Coutinho HDM, Salehi B, Tabanelli G, Montanari C, Del Mar Contreras M, Yousaf Z, Setzer WN, Verma DR, Martorell M, Sureda A, Sharifi-Rad J.
- Subjects
Farms ,Matricaria ,Phytochemicals ,01 natural sciences ,Microbiology ,Essential oil ,Azulenes ,law.invention ,Steam distillation ,chemistry.chemical_compound ,Herbal tea ,Lactones ,Sesquiterpenes, Guaiane ,Anti-Infective Agents ,law ,Coumarins ,Botany ,Hydroxybenzoates ,Oils, Volatile ,Food Industry ,Plant Oils ,Medicinal plants ,Bisabolol ,Food Preservatives ,Flavonoids ,Plants, Medicinal ,biology ,010405 organic chemistry ,Plant Extracts ,Chamazulene ,Chamomile ,food and beverages ,Antimicrobial compound ,Bacterial Infections ,biology.organism_classification ,0104 chemical sciences ,Matricaria recutita ,Monocyclic Sesquiterpenes ,010404 medicinal & biomolecular chemistry ,chemistry ,Food ,Natural food preservative ,Seasons ,Sesquiterpenes - Abstract
Matricaria is a widespread genus of flowering plants of the family Asteraceae that grow in temperate regions of Europe, Asia, America and Africa. Some of the species are also naturalized in Australia. Some species of this genus such as Chamomiles are recognized medicinal plants and cultivated in several countries for commercial purposes: to obtain its blue essence, as herbal tea, and for pharmaceutical or cosmeceutical uses. The phytochemical composition of Matricaria spp. includes volatile terpenoids (e.g., α-bisabolol, bisabolol oxide A and B, β-trans-farnesene and chamazulene), sesquiterpene lactones such as matricin, and phenolic compounds (flavonoids, coumarins and phenolic acids). Their essential oil is obtained from the fresh or dried inflorescences by steam distillation, and additionally cohobation of the remaining water. The volatile composition of the essential oil, especially the content of the valuable components α-bisabolol and chamazulene, depends on the plant part, origin and quality of the source, genetic, and environmental factors. Moreover, other parameters, such as season of harvest and methods of extraction, can affect the extraction yield of the essential oils/extracts, their composition and, therefore, their bioactivity. Due to the importance of this genus and particularly M. recutita (M. chamomilla), this review focus on its cultivation, factor affecting essential oils’ composition and their role in traditional medicine, as antibacterial agents and finally as food preservatives.
- Published
- 2017
3. Chemical composition, antibacterial potential, and toxicity of the extracts from the stem bark of Hancornia speciosa Gomes (Apocynaceae).
- Author
-
Silva VBD, Almeida-Bezerra JW, Pereira RLS, Alcântara BM, Furlan CM, Coelho JJ, Coutinho HDM, Morais-Braga MFB, and Oliveira AFM
- Subjects
- Animals, Staphylococcus aureus drug effects, Drosophila melanogaster drug effects, Escherichia coli drug effects, Pseudomonas aeruginosa drug effects, Plant Stems chemistry, Gas Chromatography-Mass Spectrometry, Plant Extracts pharmacology, Plant Extracts toxicity, Plant Extracts chemistry, Anti-Bacterial Agents pharmacology, Anti-Bacterial Agents toxicity, Anti-Bacterial Agents chemistry, Plant Bark chemistry, Microbial Sensitivity Tests, Apocynaceae chemistry
- Abstract
Ethnopharmacological Relevance: Hancornia speciosa is a medicinal plant popularly used to treat different medical issues, including infectious diseases. Exploring the therapeutic potentialities of the extracts from medicinal plants combined with conventional antibiotic drugs is a promising horizon, especially considering the rising microbial resistance., Aim of the Study: This study aimed to characterize the chemical composition of the ethereal (EEHS) and methanolic (MEHS) extracts of the stem bark of H. speciosa, and also evaluate their antibacterial and drug-modifying activity, and toxicity., Materials and Methods: The extracts were characterized by gas chromatography coupled to mass spectrometry (GC-MS). Additionally, total phenol and flavonoid contents were determined. The antibacterial and antibiotic-modifying activity was evaluated against strains of Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa using the serial microdilution method, obtaining the minimum inhibitory concentration (MIC). The toxicity assay was carried out using the Drosophila melanogaster model., Results: Thirty compounds were identified in the extracts of the stem bark of H. speciosa, with triterpenoids being predominant in both extracts. Additionally, fatty alcohols, carbohydrates, fatty acids, phenolic acids, and phytosterols were identified in both extracts. EEHS and MEHS extracts had considerable phenol contents (346.4 and 340.0 mg GAE/g, respectively). Flavonoids were detected in a lower proportion (7.6 and 6.9 mg QE/g, respectively). H. speciosa extracts did not display intrinsic antibacterial activity against the bacterial strains evaluated, however, they were capable of modifying the activity of gentamicin, erythromycin, and norfloxacin. EEHS increased the efficacy of norfloxacin against E. coli and S. aureus, reducing MIC values by 50%. MEHS potentiated the action of gentamicin against all bacterial strains, especially against E. coli. The extracts did not display toxicity at clinically relevant concentrations against D. melanogaster., Conclusion: The stem bark of H. speciosa was considered a rich source of bioactive compounds. Our findings evidenced the therapeutic potential of H. speciosa extracts for the development of new pharmaceutical therapeutics against bacteria. Although the extracts did not exhibit intrinsic antibacterial activity, they enhanced the efficacy of commercial antibiotic drugs and were non-toxic at clinically relevant concentrations. Future studies are needed to elucidate the mechanisms of action of these extracts, ensuring their safety and efficacy., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. Crotamine derived from Crotalus durissus terrificus venom combined with drugs increases in vitro antibacterial and antifungal activities.
- Author
-
de Oliveira JR, de Morais Oliveira-Tintino CD, Carneiro JNP, Dos Santos AG, de Lima AM, Soares AM, Morais-Braga MFB, Coutinho HDM, and Nicolete R
- Subjects
- Animals, Staphylococcus aureus drug effects, Drug Synergism, Candida albicans drug effects, Venomous Snakes, Antifungal Agents pharmacology, Antifungal Agents chemistry, Anti-Bacterial Agents pharmacology, Microbial Sensitivity Tests, Crotalus, Crotalid Venoms pharmacology
- Abstract
This study investigated crotamine (CTA), a peptide derived from the venom of the South American rattlesnake Crotalus durissus terrificus, known for its exceptional cell penetration potential. The objective was to explore the antibacterial and antifungal activity of CTA, its ability to inhibit efflux pumps and evaluate the effectiveness of its pharmacological combination with antibiotics and antifungals. In microbiological assays, CTA in combination with antibiotics was tested against strains of S. aureus and the inhibition of NorA, Tet(K) and MepA efflux pumps was also evaluated. CTA alone did not present clinically relevant direct antibacterial action, presenting MIC > 209.7 µM against strains S. aureus 1199B, IS-58, K2068. The standard efflux pump inhibitor CCCP showed significant effects in all negative relationships to assay reproducibility. Against the S. aureus 1199B strain, CTA (20.5 µM) associated with norfloxacin diluted 10 × (320.67 µM) showed a potentiating effect, in relation to the control. Against the S. aureus IS-58 strain, the CTA associated with tetracycline did not show a significant combinatorial effect, either with 2304 or 230.4 µM tetracycline. CTA at a concentration of 2.05 µM associated with ciprofloxacin at a concentration of 309.4 µM showed a significant potentiating effect. In association with EtBr, CTA at concentrations of 2.05 and 20.5 µM potentiated the effect in all strains tested, reducing the prevention of NorA, Tet(K) and MepA efflux pumps. In the C. albicans strain, a potentiating effect of fluconazole (334.3 µM) was observed when combined with CTA (2.05 µM). Against the C. tropicalis strain, a significant effect was also observed in the association of fluconazole 334.3 µM, where CTA 2.05 µM considerably reduced fungal growth and decreased the potentiation of fluconazole. Against the C. krusei strain, no significant potentiating effect of fluconazole was obtained by CTA. Our results indicate that CTA in pharmacological combination potentiates the effects of antibiotics and antifungal. This represents a new and promising antimicrobial strategy for treating a wide variety of infections., (© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF
5. Chemical composition and antimicrobial activity of Cordiera myrciifolia leaves against pathogenic bacteria and fungi: Drug potentiation ability and inhibition of virulence.
- Author
-
Rodrigues FC, Morais-Braga MFB, Almeida-Bezerra JW, Bezerra JJL, Fonseca VJA, de Araújo ACJ, Coutinho HDM, Ribeiro PRV, Canuto KM, Mendonça ACAM, and de Oliveira AFM
- Subjects
- Plant Leaves chemistry, Inhibitory Concentration 50, Gas Chromatography-Mass Spectrometry, Microbial Sensitivity Tests, Anti-Infective Agents chemistry, Anti-Infective Agents pharmacology, Rubiaceae chemistry, Bacteria drug effects, Fungi drug effects, Plant Extracts chemistry, Plant Extracts pharmacology
- Abstract
Cordiera myrciifolia is an abundant species in Northeast Brazil that presents metabolites of biological/therapeutic interest. From this perspective, the present study aimed to investigate the chemical constituents and evaluate the in vitro antimicrobial activity of hexane (HECM) and ethanolic (EECM) extracts of C. myrciifolia leaves. The extracts were analyzed by chromatographic techniques (GC and UPLC) coupled with mass spectrometry. The antimicrobial activity of the extracts and the extracts combined with conventional drugs was evaluated by microdilution. The in vitro effect of the treatments on Candida's morphological transition was verified through cultivation in humid chambers. In HECM, 11 constituents including fatty acids, and triterpenes, including phytosterols, alkanes, tocols, and primary alcohols were identified. Triterpenes represented >40% of the identified constituents, with Lupeol being the most representative. In EECM, 13 constituents were identified, of which eight belonged to the class of flavonoids. High antibacterial activity of HECM was detected against Escherichia coli and Staphylococcus aureus, with Minimum Inhibitory Concentrations of 8 and 16 μg/mL, respectively. The combined activity was more effective when combined with Norfloxacin and Imipenem. In anti-Candida activity, the IC
50 of the extracts ranged from 36.6 to 129.1 μg/mL. There was potentiating effect when associated with Fluconazole. Both extracts inhibited the filamentous growth of C. tropicalis at a concentration of 512 μg/mL. C. myrciifolia extracts prove to be candidates for the development of new therapeutic formulations to treat bacterial and fungal infections., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
6. In vitro Evaluation of Fungal Susceptibility and Inhibition of Virulence by Diosgenin.
- Author
-
do Socorro Costa M, da Silva ARP, Santos Araújo J, Dos Santos ATL, Fonseca VJA, Gonçalves Alencar G, Moura TF, Gonçalves SA, Filho JMB, Morais-Braga MFB, Andrade-Pinheiro JC, and Coutinho HDM
- Subjects
- Virulence drug effects, Candida albicans drug effects, Candida albicans pathogenicity, Diosgenin pharmacology, Diosgenin chemistry, Diosgenin analogs & derivatives, Antifungal Agents pharmacology, Antifungal Agents chemistry, Microbial Sensitivity Tests, Candida drug effects
- Abstract
Fungal infections are a public health problem that mainly affects immunosuppressed people, Candida spp. have been responsible for most sources of contamination and invasive fungal infections described around the world. The need arises to find new therapeutic approaches to combat growing infections. Plants and natural products have been considered a valuable source for discovering new molecules with active ingredients. Diosgenin is a sapogenin found in the families of Leguminosae and Dioscoreaceae, it is obtained mainly from the dioscin saponin through the hydrolysis method, it is a phytochemical that has been highlighted in the treatment of various diseases, as well as in combating microbial resistance. The present study aimed to evaluate the susceptibility of fungal strains to diosgenin, as well as verify the association with the reference drug and evaluate the inhibition of the virulence factor through morphological changes in the yeast state to the filamentous form of hyphae and pseudohyphae in strains of Candida albicans, Candida tropicalis and Candida krusei using the broth microdilution method and microculture technique. Antifungal assays revealed that diosgenin was not able to inhibit the growth of the tested strains. However, it was able to inhibit the fungal dimorphism of the strains evaluated, however further studies are recommended to verify its effectiveness against other virulence factors., (© 2024 Wiley-VHCA AG, Zurich, Switzerland.)
- Published
- 2024
- Full Text
- View/download PDF
7. Pharmacological potential of limonene against opportunistic fungi: Impact on Candida virulence.
- Author
-
Novais MHG, Farias NS, Dos Santos AG, Fonseca VJA, Ribeiro-Filho J, De Menezes IRA, Coutinho HDM, and Morais-Braga MFB
- Subjects
- Humans, Fluconazole pharmacology, Limonene pharmacology, Saccharomyces cerevisiae, Virulence, Fungi, Microbial Sensitivity Tests, Candida, Antifungal Agents pharmacology
- Abstract
The present article aims to evaluate the antifungal and antivirulence effect of the phytoconstituent Limonene against Candida spp. Antifungal assays were performed, where the concentration capable of inhibiting 50 % of fungal growth, the growth inhibition curve, the minimum fungicidal concentration, the evaluation of the modifying effect with fluconazole, the inhibitory effect of the substances on the morphological transition of Candida spp. and the statistical analysis of the results were determined. With this study, it was seen that limonene demonstrated growth inhibition for the strains tested and when associated the natural compound with Fluconazole, there was potentiation of the effect of the drug, since the inhibition of growth by the combination occurred at lower concentrations against all strains tested, when compared to the drug alone, which inhibited growth at the highest concentration. In the test to determine the Minimum Fungicidal Concentration of the products tested alone and in combination, it was found that in the case of Candida strains, growth inhibition by limonene occurred at a concentration of 1024 μg/mL. For Fluconazole, growth impairment ranged from > 1024 μg/mL to 256 μg/mL for the strains. And when combined, limonene potentiated the action of FCZ, making fungal colonization unfeasible at concentrations below 1024 μg/mL. Regarding the morphological transition from yeast to hyphae, limonene was used at concentrations of 1024 μg/mL and 512 μg/mL, and it was found that, for CA and CK, the filaments were reduced in number and size at the highest concentration and against CT, the morphological transition from yeast to hyphae/pseudohyphae was totally inhibited, and if compared to the growth control, limonene was able to reduce fungal growth at concentrations greater than 512 μg/mL. This compound has antimicrobial activity described, due to its ability to interfere in the gene expression of the fungus, the limited therapeutic options and the recent emergence of multidrug-resistant Candida species represent a significant challenge for human medicine and highlight the need for new therapeutic approaches, and in this study a great potential of limonene was revealed in relation to the perspective of increasing the efficiency of commercial drug. This work can bring an important contribution to the scientific database, while emphasizing that in-depth studies and tests on the subject, in order to better investigate its effectiveness and mechanisms by which they exert their effects, are still necessary., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financialinterestsor personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
8. Chemical composition, antifungal, and anti-virulence action of the stem bark of Hancornia speciosa Gomes (Apocynaceae) against Candida spp.
- Author
-
Silva VBD, Almeida-Bezerra JW, Novais MHG, Farias NS, Coelho JJ, Ribeiro PRV, Canuto KM, Coutinho HDM, Morais-Braga MFB, and Oliveira AFM
- Subjects
- Antifungal Agents pharmacology, Antifungal Agents chemistry, Candida, Fluconazole pharmacology, Virulence, Chromatography, Liquid, Plant Bark chemistry, Anthocyanins pharmacology, Plant Extracts pharmacology, Plant Extracts chemistry, Tandem Mass Spectrometry, Candida albicans, Phytochemicals analysis, Microbial Sensitivity Tests, Apocynaceae chemistry, Candidiasis, Communicable Diseases
- Abstract
Ethnopharmacological Relevance: Hancornia speciosa Gomes is a fruit and medicinal species used for treating infectious diseases of the genitourinary system. However, its mechanism of action against microbes is still not fully understood. Infections in the genitourinary system caused by Candida spp. are associated with its fungal resistance and pathogenicity. New plant-derived compounds are an alternative to fight these Candida infections., Aim of the Study: The objective of this study was to evaluate the anti-Candida effects of extracts of the stem bark of H. speciosa. This research investigated the chemical composition of sulfuric ether (EEHS) and methanolic (MEHS) extracts, their drug-modifying action on fluconazole, and their anti-virulence action on the morphological transition of Candida species., Materials and Methods: The extracts (EEHS and MEHS) of the stem bark of H. speciosa were chemically characterized via qualitative phytochemical screening and by liquid chromatography coupled with mass spectrometry (UPLC-MS-ESI-QTOF). The extracts were evaluated regarding their antifungal effects and fluconazole-modifying activity against Candida albicans, Candida krusei, and Candida tropicalis using the broth microdilution method. Additionally, the study evaluated the inhibition of fungal virulence in Candida species through morphological transition assays., Results: The phytochemical screening revealed the presence of anthocyanidins, anthocyanins, aurones, catechins, chalcones, flavones, flavonols, flavanones, leucoanthocyanidins, tannins (condensed and pyrogallic), and xanthones in both extracts of the stem bark of H. speciosa. The UPLC-MS-ESI-QTOF analysis identified the same compounds in both extracts, predominating phenolic compounds. Some compounds were first time recorded in this species: gluconic acid, cinchonain IIb, cinchonain Ib isomer, and lariciresinol hexoside isomers. Most of the intrinsic antifungal activity was observed for the MEHS against C. krusei (IC
50 : 58.41 μg/mL). At subinhibitory concentrations (MC/8), the EEHS enhanced the action of fluconazole against all Candida strains. The MEHS exhibited greater efficacy than fluconazole inhibiting C. krusei growth. The EEHS completely inhibited hyphae appearance and reduced pseudohyphae formation in C. albicans., Conclusion: The stem bark of H. speciosa is a rich source of bioactive compounds, especially phenolic. Phenolic compounds can have important roles in fighting infectious diseases of the genitourinary system, such as candidiasis. The extracts of H. speciosa improved the action of the drug fluconazole against Candida species, inhibited hyphae appearance, and reduced pseudohyphae formation. The results of this study can support the development of new therapeutics against resistant strains of Candida., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier B.V. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
9. Synthesis of chalcones and their antimicrobial and drug potentiating activities.
- Author
-
Dos Santos ATL, de Araújo-Neto JB, Costa da Silva MM, Paulino da Silva ME, Carneiro JNP, Fonseca VJA, Coutinho HDM, Bandeira PN, Dos Santos HS, da Silva Mendes FR, Sales DL, and Morais-Braga MFB
- Subjects
- Antifungal Agents chemistry, Fluconazole pharmacology, Staphylococcus aureus, Norfloxacin pharmacology, Escherichia coli, Acetone pharmacology, Anti-Bacterial Agents chemistry, Candida albicans, Penicillins pharmacology, Microbial Sensitivity Tests, Chalcones pharmacology, Chalcones chemistry, Anti-Infective Agents pharmacology, Anti-Infective Agents chemistry
- Abstract
The increased resistance of microorganisms to antimicrobial drugs makes it necessary to search for new active compounds, such as chalcones. Their simple chemical structure makes them molecules easy to synthesize. Therefore, the aim of this study was to evaluate the antimicrobial and potentiating activity of antibiotics and antifungals by synthetic chalcones against strains of Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa, Candida albicans and Candida tropicalis. The synthesis of chalcones was carried out by Claisen-Schimidt aldol condensation. Nuclear Magnetic Resonance (NMR) and Gas Chromatography Coupled to Mass Spectrometry (GC/MS) were also performed. Microbiological tests were performed by the broth microdilution method, using gentamicin, norfloxacin and penicillin as standard drugs for the antibacterial assay, and fluconazole for the antifungal assay. Three chalcones were obtained (1E,4E)-1,5-diphenylpenta-1,4-dien-3-one (DB-Acetone), (1E,3E,6E,8E)-1,9-diphenylnone-1,3,6,8-tetraen-5-one (DB-CNM), (1E,4E)-1,5-bis (4-methoxyphenyl) penta-1,4-dien-3-one (DB-Anisal). The compound DB-Acetone was able to inhibit P. aeruginosa ATCC 9027 at a concentration of 1.4 × 10
2 μM (32 μg/mL), while DB-CNM and DB-Anisal inhibited the growth of S. aureus ATCC 25923 at 17.88 × 102 μM and 2.71 × 101 μM (512 μg/mL and 8 μg/mL) respectively. In the combined activity, DB-Anisal was able to potentiate the effect of the three antibacterial drugs tested against E. coli 06, norfloxacin (128 for 4 μg/mL ±1) against P. aeruginosa 24 and penicillin (1,024 for 16 μg/mL ±1) against S. aureus 10. In antifungal assays, chalcones were not able to inhibit the growth of fungal strains tested. However, both showed potentiating activity with fluconazole, ranging from 8.17 x 10-1 μM (0.4909 μg/mL) to 2.35 μM (13.96 μg/mL). It is concluded that synthetic chalcones have antimicrobial potential, demonstrating good intrinsic activity against fungi and bacteria, in addition to potentiating the antibiotics and antifungal tested. Further studies are needed addressing the mechanisms of action responsible for the results found in this work., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2023 Elsevier Ltd. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
10. LC-MS Analysis and Antifungal Activity of Turnera subulata Sm.
- Author
-
Andrade-Pinheiro JC, Sobral de Souza CE, Ribeiro DA, Silva AA, da Silva VB, Dos Santos ATL, Juno Alencar Fonseca V, de Macêdo DG, da Cruz RP, Almeida-Bezerra JW, Machado AJT, de Freitas TS, de Brito ES, Ribeiro PRV, da Costa JGM, Coutinho HDM, Kowalska G, Rowiński R, Kowalski R, and Morais-Braga MFB
- Abstract
Fungi of the Candida genus are responsible for invasive candidiasis, which affects people all over the world and has high mortality rates. This is due to their virulence factors, which give them great resistance and pathogenicity. In addition, the emergence of multidrug-resistant strains makes it difficult to treat these infections. In this way, natural products have emerged as an alternative to standard drugs, where plants known for their medicinal properties such as Turnera subulata become attractive to research. The present work aimed to analyze the ethanol extract of Turnera subulata leaves against standard strains of Candida albicans , Candida krusei and Candida tropicalis using broth microdilution techniques. The identification of the compounds in T. subulata leaves by LC-MS revealed the presence of a wide variety of substances such as carboxylic acids and terpenes, with flavonoids and fatty acids being more evident. The antifungal assays showed that the extract was not able to inhibit the growth of the tested strains at concentrations with a clinical relevance. However, at higher concentrations, it was able to inhibit the fungal dimorphism of C. albicans and C. tropicalis . It is possible that the T. subulata extract has potential as an inhibitor of fungal virulence factors without affecting the cell viability. Further research should be carried out in order to assess its inhibitory potential for other fungal virulence factors.
- Published
- 2023
- Full Text
- View/download PDF
11. UPLC-MS-ESI-QTOF Analysis and Antifungal Activity of Aqueous Extracts of Spondias tuberosa .
- Author
-
Santos ATLD, Carneiro JNP, da Cruz RP, Sales DL, Andrade-Pinheiro JC, de Freitas MA, Kerntopf MR, Delmondes GA, Ribeiro PRV, de Brito ES, Batista FLA, Magalhães FEA, Pita Neto IC, Morais-Braga MFB, Kowalski R, Kowalska G, Szopa A, Baj T, and Coutinho HDM
- Subjects
- Chromatography, Liquid, Chromatography, High Pressure Liquid, Plant Extracts chemistry, Tandem Mass Spectrometry, Candida albicans, Candida tropicalis, Microbial Sensitivity Tests, Antifungal Agents chemistry, Fluconazole pharmacology
- Abstract
This study aimed to identify the chemical composition of the Spondias tuberosa aqueous leaf and root extracts (EALST and EARST) and to evaluate their effect, comparatively, against opportunistic pathogenic fungi. Ultra-Performance Liquid Chromatography Coupled to a Quadrupole/Time of Flight System (UPLC-MS-ESI-QTOF) was employed for chemical analysis. Candida albicans and C. tropicalis standard strains and clinical isolates were used (CA INCQS 40006, CT INCQS 40042, CA URM 5974, and CT URM 4262). The 50% Inhibitory Concentration for the fungal population (IC
50 ) was determined for both the intrinsic action of the extracts and the extract/fluconazole (FCZ) associations. The determination of the Minimum Fungicidal Concentration (MFC) and the verification of effects over fungal morphological transitions were performed by subculture in Petri dishes and humid chambers, respectively, both based on micro-dilution. UPLC-MS-ESI-QTOF analysis revealed the presence of phenolic and flavonoid compounds. The association of the extracts with fluconazole, resulted in IC50 values from 2.62 µg/mL to 308.96 µg/mL. The MFC of the extracts was ≥16,384 µg/mL for all tested strains, while fluconazole obtained an MFC of 8192 µg/mL against C. albicans strains. A reduction in MFC against CA URM 5974 (EALST: 2048 µg/mL and EARST: 1024 µg/mL) occurred in the extract/fluconazole association.- Published
- 2022
- Full Text
- View/download PDF
12. Chemical Composition and Antimicrobial Potential of Essential Oil of Acritopappus confertus (Gardner) R.M.King & H.Rob. (Asteraceae).
- Author
-
da Cruz RP, Castro JWG, Leite DOD, de Carvalho NKG, Almeida-Bezerra JW, Pereira RLS, Rodrigues FFG, Bezerra JJL, Costa AR, Mori E, de Farias PAM, Coutinho HDM, Morais-Braga MFB, Iriti M, da Costa JGM, and Rodrigues FFG
- Abstract
Microbial resistance has become a worrying problem in recent decades after the abusive use of antibiotics causing the selection of resistant microorganisms. In order to circumvent such resistance, researchers have invested efforts in the search for promising natural substances, such as essential oils. Thus, the objective of this work was to determine the chemical composition of the essential oil of Acritopappus confertus leaves, to evaluate its intrinsic effect and its effects in combination with drugs against pathogenic fungi and bacteria, in addition to verifying the inhibition of virulence in Candida strains. To this end, the oil was verified by gas chromatography coupled with mass spectrometry (GC/MS). Candida strains were used for antifungal assays by means of the serial microdilution technique, in order to determine the average inhibitory concentration (IC
50 ), and for the modification assays, sub-inhibitory concentrations (MIC/8) were used. Finally, the natural product's ability to inhibit the formation of filamentous structures was evaluated. In antibacterial tests, the MIC of the oil against strains of Staphylococcus aureus and Escherichia coli and its modifying effects in association with gentamicin, erythromycin, and norfloxacin were determined. The major constituent of the essential oil was the monoterpene myrcene (54.71%). The results show that the essential oil has an antifungal effect, with C. albicans strains being the most susceptible. Furthermore, the oil can potentiate the effect of fluconazole against strains of C. tropicalis and C. albicans. Regarding its effect on micromorphology, the oil was also able to inhibit the filaments in all strains. In combination with antibiotics, the oil potentiated the drug's action by reducing the MIC against E. coli and S. aureus . It can be concluded that the essential oil of A. confertus has potential against pathogenic fungi and bacteria, making it a target for the development of an antimicrobial drug.- Published
- 2022
- Full Text
- View/download PDF
13. The Genus Miconia Ruiz & Pav. (Melastomataceae): Ethnomedicinal Uses, Pharmacology, and Phytochemistry.
- Author
-
da Silva VB, Almeida-Bezerra JW, Costa AR, Morais-Braga MFB, de Oliveira MG, Pinheiro AAV, Sampaio RSL, Castro JWG, Dos Santos MAF, Ulisses VRA, Pereira MEDSS, Souza DL, Alcântara BM, Generino MEM, Silva JTDC, Filho AM, Silva SBD, Moon M, Kim B, and Costa JGMD
- Subjects
- Ethnopharmacology, Medicine, Traditional, Phytochemicals chemistry, Phytochemicals pharmacology, Phytochemicals therapeutic use, Phytotherapy, Plant Extracts chemistry, Plant Extracts pharmacology, Melastomataceae
- Abstract
Species of the genus Miconia are used in traditional medicine for the treatment of diseases, such as pain, throat infections, fever, and cold, and they used as depuratives, diuretics, and sedatives. This work reviewed studies carried out with Miconia species, highlighting its ethnomedicinal uses and pharmacological and phytochemical potential. This information was collected in the main platforms of scientific research (PubMed, Scopus, and Web of Science). Our findings show that some of the traditional uses of Miconia are corroborated by biological and/or pharmacological assays, which demonstrated, among other properties, anti-inflammatory, analgesic, antimutagenic, antiparasitic, antioxidant, cytotoxic, and antimicrobial activities. A total of 148 chemical compounds were identified in Miconia species, with phenolic compounds being the main constituents found in the species of this genus. Such phytochemical investigations have demonstrated the potential of species belonging to this genus as a source of bioactive substances, thus reinforcing their medicinal and pharmacological importance.
- Published
- 2022
- Full Text
- View/download PDF
14. Caryocar coriaceum Wittm. (Caryocaraceae): Botany, Ethnomedicinal Uses, Biological Activities, Phytochemistry, Extractivism and Conservation Needs.
- Author
-
Almeida-Bezerra JW, Bezerra JJL, Silva VBD, Coutinho HDM, Costa JGMD, Cruz-Martins N, Hano C, Menezes SA, Morais-Braga MFB, and Oliveira AFM
- Abstract
Caryocar coriaceum is an endemic tree of Brazil, occurring mainly in the northeast region in the Cerrado environment. The species, popularly known as "pequi", produces fruits that are used in the manufacture of oil for food and medicinal purposes. This work reviewed studies conducted with the species, highlighting its ethnomedicinal use, its pharmacological potential, including its chemical constituents, and its cultural and socioeconomic importance. Information was obtained through the main scientific research platforms. The keyword " Caryocar coriaceum " was used as the main index for searching the following platforms: PubMed
® , PubMed Central® , SciElo, Scopus® and Web of ScienceTM . The compiled papers demonstrate that C. coriaceum has great medicinal, economic and cultural importance for northeastern Brazil. Popularly, the fruits of C. coriaceum are used to treat broncho-pulmonary diseases (bronchitis, colds and flu). The fixed oil is widely used to relieve pain from various causes in the treatment of inflammation, flu, eczema, burns, fever, rickets, indigestion, heart murmurs, fatigue and erectile dysfunction. Some of these uses are corroborated by pharmacological trials, which have demonstrated the antioxidant, healing, anti-inflammatory, gastroprotective, antinociceptive and antimicrobial properties of the species. Chemically, fatty acids and phenolic compounds are the main constituents recorded for the species. Due to its medicinal properties, the fruits and oil of C. coriaceum have a high commercial demand and are one of the main forms of subsistence activities for local populations. On the other hand, the extractive practice of the fruits, associated with anthropic factors and its physiological nature, makes the species threatened with extinction. Thus, public management policies are highly necessary in order to avoid its extinction.- Published
- 2022
- Full Text
- View/download PDF
15. Evaluation of the antifungal activity of α, β, and δ-damascone and inclusion complexes in β-cyclodextrin against Candida spp.
- Author
-
de Oliveira MRC, de Lima Silva MG, Dos Santos ATL, Batista FLA, da Costa RHS, Martins AOBPB, da Cruz BG, Morais-Braga MFB, Coutinho HDM, Magalhães FEA, de Sena Junior DM, Teixeira AMR, and de Menezes IRA
- Subjects
- Candida, Fluconazole pharmacology, Microbial Sensitivity Tests, Norisoprenoids pharmacology, Antifungal Agents chemistry, Antifungal Agents pharmacology, beta-Cyclodextrins pharmacology
- Abstract
Due to the increase in fungal resistance to existing drugs, a need exists to search for new antifungals. This study aimed to evaluate the antifungal activity of α, β, and δ-damascone and inclusion complexes with β-cyclodextrin against different Candida spp. The inclusion complex of β-damascone was prepared by the co-evaporation method using three molar proportions (1:1; 2:1; 3:1 (βDA-βCD)) and analyzed using Fourier transform infrared spectroscopy (FTIR). Standard Candida albicans (CA INCQS 40,006), Candida krusei (CK INCQS 40,095), and Candida tropicalis (CT INCQS 40,042) strains were used to evaluate antifungal activity. The substances were tested individually or in association with fluconazole (FCZ). The IC
50 and cell viability curve constructions were performed using the microdilution method. The minimum fungicidal concentration (MFC) was determined by the subculture method in a solid medium. The α, β, and δ-DA isolated or in combination with fluconazole (FCZ) showed significant antifungal activity. β-damascone showed effective complexation in the three molar proportions assayed; however, none of the inclusion complexes was demonstrated clinically significant effects against the fungal tested. Then, all compounds have shown promising antifungal activities; however, in vivo assays are necessary to have therapeutical application in the future., (© 2022. Institute of Microbiology, Academy of Sciences of the Czech Republic, v.v.i.)- Published
- 2022
- Full Text
- View/download PDF
16. Lectins ConA and ConM extracted from Canavalia ensiformis (L.) DC and Canavalia rosea (Sw.) DC inhibit planktonic Candida albicans and Candida tropicalis.
- Author
-
Fonseca VJA, Braga AL, de Almeida RS, da Silva TG, da Silva JCP, de Lima LF, Dos Santos MHC, Dos Santos Silva RR, Teixeira CS, Coutinho HDM, and Morais-Braga MFB
- Subjects
- Antifungal Agents pharmacology, Canavalia metabolism, Candida metabolism, Concanavalin A, Fluconazole pharmacology, Lectins pharmacology, Microbial Sensitivity Tests, Plankton, Candida albicans, Candida tropicalis
- Abstract
Lectins participate in the defense against microorganisms and in signaling the damage caused by pathogens to the cell surface and/or intracellular in plants. This study aims to analyze the antifungal potential of lectins extracted from seeds of Canavalia ensiformis (L.) DC and Canavalia rosea (Sw.) DC, against Candida albicans and Candida tropicalis. The antimicrobial tests were performed by microdilution against Candida spp. The test to verify the combined lectin/fluconazole effect was performed using subinhibitory concentrations of lectins and with antifungal ranging from 0.5 to 512 µg/mL. The ability to inhibit the morphological transition of Candida spp. was evaluated by microcultivation in a moist chamber. The results of the minimum inhibitory concentration revealed no antifungal activity against the tested strains. However, lectins modified the action of fluconazole, reducing the IC
50 of the drug against C. albicans. Lectins were also able to discretely modulate the morphological transition of the tested strains., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2022
- Full Text
- View/download PDF
17. Phytochemical Analysis, Antibacterial Activity and Modulating Effect of Essential Oil from Syzygium cumini (L.) Skeels.
- Author
-
Fernandes PAS, Pereira RLS, Santos ATLD, Coutinho HDM, Morais-Braga MFB, da Silva VB, Costa AR, Generino MEM, de Oliveira MG, de Menezes SA, Santos LTD, Siyadatpanah A, Wilairatana P, Portela TMA, Gonçalo MABF, and Almeida-Bezerra JW
- Subjects
- Anti-Bacterial Agents chemistry, Anti-Bacterial Agents pharmacology, Escherichia coli, Gas Chromatography-Mass Spectrometry, Humans, Phytochemicals pharmacology, Pseudomonas aeruginosa, Staphylococcus aureus, Oils, Volatile chemistry, Oils, Volatile pharmacology, Syzygium
- Abstract
One of the main global problems that affect human health is the development of bacterial resistance to different drugs. As a result, the growing number of multidrug-resistant pathogens has contributed to an increase in resistant infections and represents a public health problem. The present work seeks to investigate the chemical composition and antibacterial activity of the essential oil of Syzygium cumini leaves. To identify its chemical composition, gas chromatography coupled to mass spectrometry was used. The antibacterial activity test was performed with the standard strains Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 25853 and Staphylococcus aureus ATCC 25923 and multidrug-resistant clinical isolates E. coli 06, P. aeruginosa 24 and S. aureus 10. The minimum inhibitory concentration (MIC) was determined by serial microdilution as well as the verification of the modulating effect of the antibiotic effect. In this test, the oil was used in a subinhibitory concentration. The test reading was performed after 24 h of incubation at 37 °C. The results show that the major chemical constituent is α-pinene (53.21%). The oil showed moderate activity against E. coli ATCC 25922, with the MIC of 512 µg/mL; there was no activity against the other strains. The oil potentiated the effect of antibiotics demonstrating possible synergism when associated with gentamicin, erythromycin and norfloxacin against E. coli 06 and S. aureus 10.
- Published
- 2022
- Full Text
- View/download PDF
18. A Potential New Source of Therapeutic Agents for the Treatment of Mucocutaneous Leishmaniasis: The Essential Oil of Rhaphiodon echinus .
- Author
-
Oliveira CVB, Silva PAGD, Tintino SR, Coronel CC, Gomez MCV, Rolón M, Cunha FABD, Morais-Braga MFB, Coutinho HDM, Siyadatpanah A, Wilairatana P, Kamdem JP, Barros LM, Duarte AE, and Pereira PS
- Subjects
- Animals, Antioxidants pharmacology, Mammals, Antiprotozoal Agents pharmacology, Chagas Disease drug therapy, Lamiaceae, Leishmaniasis, Mucocutaneous, Oils, Volatile pharmacology, Trypanosoma cruzi
- Abstract
Weeds are an important source of natural products; with promising biological activity. This study investigated the anti-kinetoplastida potential (in vitro) to evaluate the cytotoxicity (in vitro) and antioxidant capacity of the essential oil of Rhaphiodon echinus (EORe), which is an infesting plant species. The essential oil was analyzed by GC/MS. The antioxidant capacity was evaluated by reduction of the DPPH radical and Fe
3+ ion. The clone Trypanosoma cruzi CL-B5 was used to search for anti-epimastigote activity. Antileishmanial activity was determined using promastigotes of Leishmania braziliensis (MHOM/CW/88/UA301). NCTC 929 fibroblasts were used for the cytotoxicity test. The results showed that the main constituent of the essential oil was γ-elemene. No relevant effect was observed concerning the ability to reduce the DPPH radical; only at the concentration of 480 μg/mL did the essential oil demonstrate a high reduction of Fe3+ power. The oil was active against L. brasiliensis promastigotes; but not against the epimastigote form of T. cruzi . Cytotoxicity for mammalian cells was low at the active concentration capable of killing more than 70% of promastigote forms. The results revealed that the essential oil of R. echinus showed activity against L. brasiliensis ; positioning itself as a promising agent for antileishmanial therapies.- Published
- 2022
- Full Text
- View/download PDF
19. Anti- Candida Properties of Gossypium hirsutum L.: Enhancement of Fungal Growth, Biofilm Production and Antifungal Resistance.
- Author
-
de Lima LF, Andrade-Pinheiro JC, Freitas MA, da Silva AI, Fonseca VJA, da Silva TG, da Silva JCP, de Lima RH, Sales DL, Neves RP, de Brito ES, Ribeiro PRV, Canuto KM, Coutinho HDM, Siyadatpanah A, Kim B, and Morais-Braga MFB
- Abstract
(1) Background: Candida is a genus of yeasts with notable pathogenicity and significant ability to develop antimicrobial resistance. Gossypium hirsutum L., a medicinal plant that is traditionally used due to its antimicrobial properties, has demonstrated significant antifungal activity. Therefore, this study investigated the chemical composition and anti- Candida effects of aqueous (AELG) and hydroethanolic (HELG) extracts obtained from the leaves of this plant. (2) Methods: The extracts were chemically characterized by UPLC-QTOF-MS/MS, and their anti- Candida activities were investigated by analyzing cell viability, biofilm production, morphological transition, and enhancement of antifungal resistance. (3) Results: The UPLC-QTOF-MS/MS analysis revealed the presence of twenty-one compounds in both AELG and HELG, highlighting the predominance of flavonoids. The combination of the extracts with fluconazole significantly reduced its IC
50 values against Candida albicans INCQS 40006, Candida tropicalis INCQS 40042, and C. tropicalis URM 4262 strains, indicating enhanced antifungal activity. About biofilm production, significant inhibition was observed only for the AELG-treated C. tropicalis URM 4262 strain in comparison with the untreated control. Accordingly, this extract showed more significant inhibitory effects on the morphological transition of the INCQS 40006 and URM 4387 strains of C. albicans (4) Conclusions: Gossypium hirsutum L. presents promising antifungal effects, that may be potentially linked to the combined activity of chemical constituents identified in its extracts.- Published
- 2022
- Full Text
- View/download PDF
20. HPLC-DAD analysis and antimicrobial activities of Spondias mombin L. (Anacardiaceae).
- Author
-
de Freitas MA, da Cruz RP, Dos Santos ATL, Almeida-Bezerra JW, Machado AJT, Dos Santos JFS, Rocha JE, Boligon AA, Bezerra CF, de Freitas TS, do Nascimento Silva MK, Mendonça ACAM, da Costa JGM, Coutinho HDM, da Cunha FAB, Filho JR, and Morais-Braga MFB
- Abstract
Spondias mombin is used in the folk medicine for the treatment of diarrhea and dysentery, indicating that extracts obtained from this species may present pharmacological activities against pathogenic microorganisms. The purpose of this work was to investigate the chemical composition and evaluate the antimicrobial activity of extracts obtained from the leaves (aqueous) and bark (hydroethanolic) of S. mombin both as single treatments and in combination with conventional drugs. Following a qualitative chemical prospection, the extracts were analyzed by HPLC-DAD. The antimicrobial activities were evaluated by microdilution. The combined activity of drugs and extracts was verified by adding a subinhibitory concentration of the extract in the presence of variable drug concentrations. The Minimum Fungicidal Concentration (MFC) was determined by a subculture of the microdilution test, while the effect of the in vitro treatments on morphological transition was analyzed by subculture in moist chambers. While the qualitative analysis detected the presence of phenols and flavonoids, the HPLC analysis identified quercetin, caffeic acid, and catechin as major components in the leaf extract, whereas kaempferol and quercetin were found as major compounds in the bark extract. The extracts showed effective antibacterial activities only against the Gram-negative strains. With regard to the combined activity, the leaf extract potentiated the action of gentamicin and imipenem (against Staphylococcus aureus ), while the bark extract potentiated the effect of norfloxacin (against S. aureus ), imipenem (against Escherichia coli ), and norfloxacin (against Pseudomonas aeruginosa ). A more significant antifungal (fungistatic) effect was achieved with the bark extract (even though at high concentrations), which further enhanced the activity of fluconazole. The extracts also inhibited the emission of filaments by Candida albicans and Candida tropicalis . Together, these findings suggest that that the extract constituents may act by favoring the permeability of microbial cells to conventional drugs, as well as by affecting virulence mechanisms in Candida strains ., (© King Abdulaziz City for Science and Technology 2022.)
- Published
- 2022
- Full Text
- View/download PDF
21. A review on the antimicrobial properties of lectins.
- Author
-
Fonseca VJA, Braga AL, Filho JR, Teixeira CS, da Hora GCA, and Morais-Braga MFB
- Subjects
- Carbohydrates chemistry, Drug Development, Drug Resistance, Microbial drug effects, Anti-Infective Agents pharmacology, Plant Lectins pharmacology
- Abstract
Lectins are biologically versatile biomolecules with remarkable antimicrobial effects, notably against bacteria, fungi and protozoa, in addition to modulating host immunity. For this, the lectins bind to carbohydrates on the surface of the pathogen, which can cause damage to the cell wall and prevent the attachment of microorganisms to host cells. Thus, this study intends to review the biological activities of lectins, with an emphasis on antimicrobial activity. Lectins of plant stood out for its antimicrobial effects, demonstrating that they act against a variety of strains, where in vitro were able to inhibit their development and affect their morphology. In vivo, they modulated host immunity, signaling and activating defense cells. Some of these lectins were capable to modulate the action of antibiotics, indicating their potential to minimize the antibiotic resistance. The results suggest that lectins have antimicrobial activity with potential to be used in drug development., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
22. Ethnobotanical and antimicrobial activities of the Gossypium (Cotton) genus: A review.
- Author
-
Lima LF, Oliveira JO, Carneiro JNP, Lima CNF, Coutinho HDM, and Morais-Braga MFB
- Subjects
- Animals, Anti-Infective Agents isolation & purification, Ethnobotany, Ethnopharmacology, Gossypium classification, Humans, Medicine, Traditional methods, Plant Preparations isolation & purification, Protozoan Infections drug therapy, Anti-Infective Agents pharmacology, Gossypium chemistry, Plant Preparations pharmacology
- Abstract
Ethnopharmacological Relevance: The Malvaceae family, an important group of plants that have the Gossypium (cotton) genus has been used in folk medicine to treat microbial diseases and symptoms., Aims of the Study: This article aims to understand its ethnobotany expression in communities and scientific elucidation of antimicrobial activities of this genus through literature review., Materials and Methods: The bibliographic survey was carried out from 1999 to 2019 with keywords combinations such as "Gossypium + ethnobotanical", " Gossypium + medicinal ", "Gossypium + the biological activity" in scientific databases as Pubmed, Scopus, Web of Science, DOAJ, Scielo, Bireme., Results: After data analysis, we found that the Gossypium genus, specifically Gossypium hirsutum, G. barbadense, G. herbaceum, G. arboreum are the species most cited in the treatment of microbial diseases and symptoms in communities all over the world. In light of scientific elucidation of biological activities, the Gossypium genus has been used to treat protozoal, bacterial, fungal, and viral diseases., Conclusions: The review demonstrated that the Gossypium genus is a promising source of biological activities against microbial diseases, especially in the treatment of protozoal diseases like malaria., (Copyright © 2021 Elsevier B.V. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
23. Chemical Constituents and Biological Activities of Croton heliotropiifolius Kunth.
- Author
-
Fernandes PAS, Silva JCPD, Lima Sales D, Ribeiro PRV, Sousa de Brito E, Kerntopf MR, Delmondes GA, Andrade Pinheiro JC, Salazar GJT, Batista FLA, Alves Magalhães FE, Gomez MCV, Rolón M, Coronel C, Ribeiro-Filho J, Almeida-Bezerra JW, Siyadatpanah A, Nissapatorn V, Pereira ML, Coutinho HDM, and Morais-Braga MFB
- Abstract
Croton heliotropiifolius Kunth (Euphorbiaceae), whose occurrence has already been registered in the most varied Brazilian biomes, is commonly found in the Chapada do Araripe, Ceará. The species is traditionally used to treat fungal, parasitic, and degenerative diseases. This study investigated the chemical composition and pharmacological potential (antioxidant, antifungal, antiparasitic, and cytotoxic) of an aqueous extract obtained from the roots of C. heliotropiifolius . Following a qualitative phytochemical screening, the chemical constituents were identified by ultra-efficiency liquid chromatography coupled witha quadrupole/time-of-flight system (UPLC-QTOF). The antioxidant potential was verified by thin-layer chromatography (TLC). The direct and combined antifungal activity of the extract against opportunistic Candida strains was investigated using the microdilution method. The minimal fungicidal concentration (MFC) was determined by subculture, while the modulation of the morphological transition (fungal virulence) was evaluated by light microscopy. The in vitro antiparasitic activity was analyzed using epimastigotes of Trypanosoma cruzi and promastigotes of Leishmania braziliensis and Leishmania infantum, while cytotoxicity was determined in cultures of mouse fibroblasts. The phytochemical analysis identified the presence of acids, terpenes, flavonoids, lignans, and alkaloids. Among these constituents, the presence of polar and non-polar phenolic compounds with known antioxidant action was highlighted. While the extract showed clinically ineffective antifungal effects, it could enhance the effectiveness of fluconazole, in addition to inhibiting the morphological transition associated with increased virulence in Candida strains. Although the extract showed low cytotoxicity against fibroblasts, it also had weak antiparasitic effects. In conclusion, Croton heliotropiifolius is a source of natural products with antifungal and antioxidant potential.
- Published
- 2021
- Full Text
- View/download PDF
24. Phytochemical characterization and inhibition of Candida sp. by the essential oil of Baccharis trimera (Less.) DC.
- Author
-
da Silva TG, da Silva JCP, Carneiro JNP, do Amaral W, Deschamps C, de Araújo JP, da Costa JGM, de Oliveira Almeida W, da Silva LE, Coutinho HDM, Filho JR, and Morais-Braga MFB
- Subjects
- Antifungal Agents pharmacology, Microbial Sensitivity Tests, Phytochemicals pharmacology, Pichia drug effects, Baccharis chemistry, Candida drug effects, Oils, Volatile pharmacology
- Abstract
This study aimed to investigate the chemical composition and antifungal potential of the essential oil of Baccharis trimera (Less.) DC. against Candida strains. The half maximal inhibitory concentration (IC
50 ) was assessed by the microdilution method using the essential oil at a concentration range of 8192 to 8 μg/mL. The minimum fungicide concentration (MFC) was determined by subculture in solid medium. The ability of the essential oil to modulate the activity of antifungals was determined in wells treated simultaneously with the oil at a subinhibitory concentration (MFC/16) and fluconazole (FCZ). The fungal morphology was analyzed by microscopy. Gas chromatography coupled with mass spectrometry (GC/MS) was used to identify the chemical composition. The essential oil presented an CI50 of 11.24 and 1.45 μg/mL, which was found to potentiate the effect of FCZ against Candida albicans. On the other hand, this combined treatment resulted in antagonism against Candida tropicalis and no evident modulation against Candida krusei was observed. The essential oil significantly inhibited hyphae growth. However, with a MFC ≥ 16,384 μg/mL, it is assumed that it has a fungistatic action. The antifungal properties demonstrated in this study might be related to the presence of sesquiterpenes and monoterpenes, and the interaction between them. In conclusion, Baccharis trimera showed promising anti-Candida effects, in addition to potentiating the activity of FCZ against Candida albicans, affecting its morphological transition. Therefore, this species constitutes a source of chemical compounds with the potential to be used in the combat of fungal infections., (© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)- Published
- 2021
- Full Text
- View/download PDF
25. Astragalus species: Insights on its chemical composition toward pharmacological applications.
- Author
-
Salehi B, Carneiro JNP, Rocha JE, Coutinho HDM, Morais Braga MFB, Sharifi-Rad J, Semwal P, Painuli S, Moujir LM, de Zarate Machado V, Janakiram S, Anil Kumar NV, Martorell M, Cruz-Martins N, El Beyrouthy M, and Sadaka C
- Abstract
Astragalus L. is widely distributed throughout the temperate regions of Europe, Asia, and North America. The genus is widely used in folk medicine and in dietary supplements, as well as in cosmetics, teas, coffee, vegetable gums, and as forage for animals. The major phytoconstituents of Astragalus species with beneficial properties are saponins, flavonoids, and polysaccharides. Astragalus extracts and their isolated components exhibited promising in vitro and in vivo biological activities, including antiaging, antiinfective, cytoprotective, antiinflammatory, antioxidant, antitumor, antidiabesity, and immune-enhancing properties. Considering their proven therapeutic potential, the aim of this work is to give a comprehensive summary of the Astragalus spp. and their active components, in an attempt to provide new insight for further clinical development of these xenobiotics. This is the first review that briefly describes their ethnopharmacology, composition, biological, and toxicological properties., (© 2020 John Wiley & Sons, Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
26. Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole.
- Author
-
Bezerra CF, de Alencar Júnior JG, de Lima Honorato R, Dos Santos ATL, Pereira da Silva JC, Gusmão da Silva T, Leal ALAB, Rocha JE, de Freitas TS, Tavares Vieira TA, Bezerra MCF, Sales DL, Kerntopf MR, de Araujo Delmondes G, Filho JMB, Peixoto LR, Pinheiro AP, Ribeiro-Filho J, Coutinho HDM, Morais-Braga MFB, and Gonçalves da Silva T
- Subjects
- Antifungal Agents chemistry, Drug Resistance, Fungal drug effects, Farnesol chemistry, Fluconazole chemistry, Liposomes chemistry, Liposomes pharmacology, Microbial Sensitivity Tests, Antifungal Agents pharmacology, Candida drug effects, Farnesol pharmacology, Fluconazole pharmacology
- Abstract
Candida infections represent a threat to human health. Candida albicans is the main causative agent of invasive candidiasis, especially in immunosuppressed patients. The emergence of resistant strains has required the development of new therapeutic strategies. In this context, the use of liposomes as drug carrier systems is a promising alternative in drug development. Thus, considering the evidence demonstrating that sesquiterpene farnesol is a bioactive compound with antifungal properties, this study evaluated the activity farnesol-containing liposomes against different Candida strains. The IC
50 of farnesol and its liposomal formulation was assessed in vitro using cultures of Candida albicans, Candida tropicalis, and Candida krusei. The Minimum Fungicidal Concentration (MFC) was established by subculture in solid medium. The occurrence of fungal dimorphism was analyzed using optical microscopy. The effects on antifungal resistance to fluconazole were assessed by evaluating the impact of combined therapy on the growth of Candida strains. The characterization of liposomes was carried out considering their vesicular size, polydispersion index, and zeta medium potential, in addition to electron microscopy analysis. Farnesol exerted an antifungal activity that might be associated with the inhibition of fungal dimorphism, especially in Candida albicans. The incorporation of farnesol into liposomes significantly increased its antifungal activity against C. albicans, C. tropicalis, and C. krusei. In addition, liposomal farnesol potentiated the action of fluconazole against C. albicans and C. tropicalis. On the other hand, the association of unconjugated farnesol with fluconazole resulted in antagonistic effects. In conclusion, farnesol-containing liposomes have the potential to be used in antifungal drug development. However, further research is required to investigate how the antifungal properties of farnesol are affected by the interaction with liposomes, contributing to the modulation of antifungal resistance to conventional drugs., (Copyright © 2020 Elsevier B.V. All rights reserved.)- Published
- 2020
- Full Text
- View/download PDF
27. Phytochemical characterization of the Ziziphus joazeiro Mart. metabolites by UPLC-QTOF and antifungal activity evaluation.
- Author
-
Andrade JC, Dos Santos ATL, Da Silva ARP, Freitas MA, Afzal MI, Gonçalo MIP, Fonseca VJA, Costa MDS, Carneiro JNP, Sousa EO, De Matos YMLS, De Freitas TS, De Sousa AK, Morais-Braga MFB, Coutinho HDM, Ali SW, Salehi B, Imran M, Umer M, Ul-Haque E, Setzer WN, and Sharifi-Rad J
- Subjects
- Antifungal Agents chemistry, Candida drug effects, Chromatography, High Pressure Liquid, Fluconazole pharmacology, Inhibitory Concentration 50, Microbial Viability drug effects, Phytochemicals chemistry, Plant Extracts pharmacology, Water, Antifungal Agents pharmacology, Metabolome, Phytochemicals pharmacology, Ziziphus metabolism
- Abstract
The aim of this study was to evaluate the antifungal and modulatory potential of the Ziziphus joazeiro bark and leaf extracts, both in isolation and in association with fluconazole, against resistant species from the Candida genus. Antifungal assays were used to determine the half maximal inhibitory concentration (IC50) of the extract in isolation and in combination with fluconazole using the broth microdilution method and spectrophotometric readings, followed by verification of the minimum fungicidal concentration by solid medium subculture. According to the cell viability curve, both extracts inhibited fungal growth in a concentration dependent manner, in addition to showing inhibitory concentrations similar to fluconazole. However, the extracts behaved in a fungistatic manner with minimum inhibitory concentration > 8.19 mg/mL and IC50 values ranging from 0.450 mg/mL to 9 mg/mL. The minimum inhibitory concentration for both extracts decreased when in combination with fluconazole, with the AEL standing out against Candida albicans URM 4387, displaying an IC50 equal to that of fluconazole (0.002 mg/mL). Nevertheless, fluconazole antagonism was observed against the tested strains. Overall, the evaluation of both extracts against Candida spp. presented inhibitory concentration values greater than fluconazole. Moreover, despite these being chemically complex crude extracts, they did demonstrate antifungal effects and properties that concur with their ethno-biological aspect.
- Published
- 2020
28. Antioxidant, Antimicrobial, and Anticancer Effects of Anacardium Plants: An Ethnopharmacological Perspective.
- Author
-
Salehi B, Gültekin-Özgüven M, Kirkin C, Özçelik B, Morais-Braga MFB, Carneiro JNP, Bezerra CF, da Silva TG, Coutinho HDM, Amina B, Armstrong L, Selamoglu Z, Sevindik M, Yousaf Z, Sharifi-Rad J, Muddathir AM, Devkota HP, Martorell M, Jugran AK, Cho WC, and Martins N
- Subjects
- Animals, Humans, Anacardium chemistry, Anti-Bacterial Agents pharmacology, Antineoplastic Agents pharmacology, Antioxidants pharmacology, Ethnopharmacology, Plant Extracts pharmacology
- Abstract
Anacardium plants have received increasing recognition due to its nutritional and biological properties. A number of secondary metabolites are present in its leaves, fruits, and other parts of the plant. Among the diverse Anacardium plants' bioactive effects, their antioxidant, antimicrobial, and anticancer activities comprise those that have gained more attention. Thus, the present article aims to review the Anacardium plants' biological effects. A special emphasis is also given to their pharmacological and clinical efficacy, which may trigger further studies on their therapeutic properties with clinical trials., (Copyright © 2020 Salehi, Gültekin-Özgüven, Kirkin, Özçelik, Morais-Braga, Carneiro, Bezerra, Silva, Coutinho, Amina, Armstrong, Selamoglu, Sevindik, Yousaf, Sharifi-Rad, Muddathir, Devkota, Martorell, Jugran, Cho and Martins.)
- Published
- 2020
- Full Text
- View/download PDF
29. Use of the natural products from the leaves of the fruitfull tree Persea americana against Candida sp. biofilms using acrylic resin discs.
- Author
-
de Freitas MA, Andrade JC, Alves AIS, Dos Santos FAG, Leite-Andrade MC, Sales DL, Nunes M, Ribeiro PRV, Melo Coutinho HD, Morais-Braga MFB, and Neves RP
- Subjects
- Acrylic Resins, Antifungal Agents, Biofilms, Biological Products, Candida, Microbial Sensitivity Tests, Plant Leaves, Tandem Mass Spectrometry, Trees, Persea
- Abstract
The search for natural substances such as plant extracts with antimicrobial properties has considerably increased, given that biofilms constitute a barrier against antifungal therapy, where these can be formed on any surface, such as acrylic resin prosthesis. The objective of this study was to identify the chemical composition of the Persea americana Mill. leaf ethanol extract (EEFPa) using the UPLC-QTOF-MS/MS technique, to verify its antifungal activity through a sensitivity test according to the conditions described in the documents in M27-A3 (CLSI, 2008) and M60 (CLSI, 2017), to induce biofilm formation in acrylic resin discs and quantify their formation using tetrazolium salt reduction (MTT), as well as to treat these with the extract and fluconazole. Ten of the twelve compounds present in the extract were identified. In the sensitivity test the lowest minimum inhibitory concentration observed was 512 μg/mL, while fluconazole concentrations ranged from 64 to 1 μg/mL. During biofilm induction, all the isolates were able to form biofilms within 48 h. During biofilm treatment, the extract was less effective at biofilm reduction than Fluconazole. The EEFPa showed significant antifungal activity against some of the strains in this study, however the extract showed lower effect when compared to fluconazole against the biofilm formation., (Copyright © 2019 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
30. Effect of α-Bisabolol and Its β-Cyclodextrin Complex as TetK and NorA Efflux Pump Inhibitors in Staphylococcus aureus Strains.
- Author
-
Pereira da Cruz R, Sampaio de Freitas T, Socorro Costa MD, Lucas Dos Santos AT, Ferreira Campina F, Pereira RLS, Bezerra JWA, Quintans-Júnior LJ, De Souza Araújo AA, Júnior JPS, Iriti M, Varoni EM, Menezes IRA, Melo Coutinho HD, and Morais-Braga MFB
- Abstract
Efflux pumps are proteins present in the plasma membrane of bacteria, which transport antibiotics and other compounds into the extracellular medium, conferring resistance. The discovery of natural efflux pump inhibitors is a promising alternative. α-Bisabolol is a sesquiterpene isolated from several plants such as Matricaria chamomilla L. and has important properties such as antibacterial and anti-inflammatory activity. Currently, the formation of inclusion complexes with β-Cyclodextrin has been used for improving the physicochemical characteristics of the host molecule. This study evaluated the effect of α-Bisabolol, in isolation and in complexation with β-Cyclodextrin, as TetK and NorA efflux pump inhibitors in Staphylococcus aureus strains. The minimum inhibitory concentration (MIC) was determined. Subsequently, inhibitory activity over the pumps was observed by an MIC reduction for the antibiotics, by using subinhibitory concentrations (MIC/8) in combination with tetracycline and norfloxacin. The MIC of the compounds was ≥1024 μg/mL. α-Bisabolol potentiated the action of tetracycline and reduced the MIC of norfloxacin to a clinically relevant concentration. The complexed substance showed synergism however, the effect of the isolated α-Bisabolol was superior to the complex. These results indicate α-Bisabolol is a potential substance to be used as an efflux pump inhibitor., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2020
- Full Text
- View/download PDF
31. UPLC-MS-ESI-QTOF Analysis and Antifungal Activity of the Spondias tuberosa Arruda Leaf and Root Hydroalcoholic Extracts.
- Author
-
Thassya Lucas Dos Santos A, Pereira Carneiro JN, Pereira da Cruz R, Lima Sales D, Cosmo Andrade J, de Oliveira Almeida W, Martins da Costa JG, Riceli Vasconcelos Ribeiro P, Sousa de Brito E, Alves Batista FL, Alves Magalhães FE, Iriti M, Morais-Braga MFB, and Coutinho HDM
- Abstract
The aim of this study was to identify and evaluate the chemical compositions and effects of the S. tuberosa leaf and root hydroalcoholic extracts (HELST and HERST) against different strains of Candida . Chemical analysis was performed by Ultra-Performance Liquid Chromatography Coupled to Quadrupole/Time of Flight System (UPLC-MS-ESI-QTOF). The Inhibitory Concentration of 50% of the growth (IC
50) as well as the intrinsic and combined action of the extracts with the antifungal fluconazole (FCZ) were determined by the microdilution method while the minimum fungicidal concentrations (MFCs) and the effect on fungal morphological transitions were analyzed by subculture and in humid chambers, respectively. From the preliminary phytochemical analysis, the phenols and flavonoids were the most abundant. The intrinsic IC50 values for HELST ranged from 5716.3 to 7805.8 µg/mL and from 6175.4 to 51070.9 µg/mL for the HERST, whereas the combination of the extracts with fluconazole presented IC50 values from 2.65 to 278.41 µg/mL. The MFC of the extracts, individually, for all the tested strains was ≥16384 µg/mL. When fluconazole was combined with each extract, the MFC against CA URM 5974 was reduced (HELST: 2048 and HERST: 4096 µg/mL). Synergism was observed against standard C. albicans (CA) and C. tropicalis (CT) strains and with the root extract against the CT isolate. The leaf extract inhibited the morphological transition of all strains while the root extract inhibited only CT strains.- Published
- 2019
- Full Text
- View/download PDF
32. Anacardium Plants: Chemical,Nutritional Composition and Biotechnological Applications.
- Author
-
Salehi B, Gültekin-Özgüven M, Kırkın C, Özçelik B, Morais-Braga MFB, Carneiro JNP, Bezerra CF, Silva TGD, Coutinho HDM, Amina B, Armstrong L, Selamoglu Z, Sevindik M, Yousaf Z, Sharifi-Rad J, Muddathir AM, Devkota HP, Martorell M, Jugran AK, Martins N, and Cho WC
- Subjects
- Anacardium growth & development, Food Preservation, Phytochemicals analysis, Anacardium chemistry, Biotechnology, Nutrients analysis
- Abstract
Anacardium plants are native to the American tropical regions, and Anacardium occidentale L. (cashew tree) is the most recognized species of the genus. These species contain rich secondary metabolites in their leaf and shoot powder, fruits and other parts that have shown diverse applications. This review describes the habitat and cultivation of Anacardium species, phytochemical and nutritional composition, and their industrial food applications. Besides, we also discuss the secondary metabolites present in Anacardium plants which display great antioxidant and antimicrobial effects. These make the use of Anacardium species in the food industry an interesting approach to the development of green foods., Competing Interests: The authors declare no conflict of interest.
- Published
- 2019
- Full Text
- View/download PDF
33. Chemical composition and anti-Candida potencial of the extracts of Tarenaya spinosa (Jacq.) Raf. (Cleomaceae).
- Author
-
Rodrigues FC, Dos Santos ATL, Machado AJT, Bezerra CF, de Freitas TS, Coutinho HDM, Morais-Braga MFB, Bezerra JWA, Duarte AE, Kamdem JP, Boligon AA, de Campos MMA, and Barros LM
- Subjects
- Antifungal Agents chemistry, Caffeic Acids pharmacology, Drug Discovery, Drug Synergism, Fluconazole pharmacology, Inhibitory Concentration 50, Microbial Sensitivity Tests, Plant Extracts chemistry, Plants, Medicinal chemistry, Antifungal Agents pharmacology, Candida drug effects, Phytochemicals chemistry, Phytochemicals pharmacology, Plant Extracts pharmacology
- Abstract
Phytochemical prospecting was performed by HPLC-DAD. The Inhibitory Concentration of 50% of mortality the microorganisms (IC
50 ) was determined and a cell viability curve was obtained. Minimum Fungicidal Concentration (MFC) was determined by subculture in Sabourad Dextrose Agar. The effect of the combination extract/fluconazole was verified by microdilution, with the extracts in subinhibitory concentrations (MFC/16). Caffeic acid was the major compound of both extracts, representing 6.08% in the aqueous extract and 7.62% in the ethanolic extract. The extracts showed a fungistatic effect (MFC ≥ 16,384 μg/mL). The IC50 results demonstrated that the combination of the extracts with fluconazole were more significant than the products tested alone, with values from 4.9 to 34.8 μg/mL for the ethanolic extract/fluconazole and 5 to 84.7 μg/mL for the aqueous extract/fluconazole. The potentiating effect of fluconazole action was observed against C. albicans and C. tropicalis. In C. krusei the aqueous extract had an antagonistic effect., (Copyright © 2019 Elsevier Ltd. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
34. Cholecalciferol, Ergosterol, and Cholesterol Enhance the Antibiotic Activity of Drugs.
- Author
-
Andrade JC, Morais Braga MFB, Guedes GMM, Tintino SR, Freitas MA, Quintans LJ, Jr, Menezes IRA, and Coutinho HDM
- Subjects
- Cholecalciferol chemistry, Cholesterol chemistry, Ergosterol chemistry, Microbial Sensitivity Tests, Anti-Bacterial Agents pharmacology, Cholecalciferol pharmacology, Cholesterol pharmacology, Ergosterol pharmacology
- Abstract
Background: This is the first report demonstrating the antibiotic-modifying activity of cholecalciferol., Aim: In this study, cholecalciferol was evaluated against multiresistant strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli., Methods: The antibacterial and modulatory effects of cholecalciferol, ergosterol, and cholesterol (8-512 μg/mL) were evaluated by microdilution assay against multiresistant bacterial strains., Results: Cholecalciferol, when combined with aminoglycosides, was more effective against P. aeruginosa, reducing the concentration of amikacin and gentamicin necessary to inhibit bacterial growth from 156.25 to 39.06 μg/mL and from 39.06 to 9.76 μg/mL, respectively. It is possible that cholecalciferol, due to its lipid-soluble nature, had a lipophilic interaction with the cell membrane, enhancing antibiotic uptake. Cholesterol and ergosterol were used to see if the mechanism of action of cholecalciferol was similar to that of these lipid compounds. Ergosterol and cholesterol increased aminoglycoside activity, where the effect was greater with higher subinhibitory concentration of sterol., Conclusions: There is no reported study on the use of cholesterol and ergosterol as modulators of antibiotics or any other drug, making this the first study in this area highlighting the interaction between cholesterol, ergosterol, and cholecalciferol with regard to modifying aminoglycoside activity.
- Published
- 2018
- Full Text
- View/download PDF
35. Effect of seasonality on chemical profile and antifungal activity of essential oil isolated from leaves Psidium salutare (Kunth) O. Berg.
- Author
-
de Macêdo DG, Souza MMA, Morais-Braga MFB, Coutinho HDM, Dos Santos ATL, da Cruz RP, da Costa JGM, Rodrigues FFG, Quintans-Junior LJ, da Silva Almeida JRG, and de Menezes IRA
- Abstract
Medicinal plants play a crucial role in the search for components that are capable of neutralizing the multiple mechanisms of fungal resistance. Psidium salutare (Kunth) O. Berg is a plant native to Brazil used as both food and traditional medicine to treat diseases and symptoms such as stomach ache and diarrhea, whose symptoms could be related to fungal infections from the genus Candida . The objective of this study was to investigate the influence of seasonal variability on the chemical composition of the Psidium salutare essential oil, its antifungal potential and its effect on the Candida albicans morphogenesis. The essential oils were collected in three different seasonal collection periods and isolated by the hydrodistillation process in a modified Clevenger apparatus with identification of the chemical composition determined by gas chromatography coupled to mass spectrometry (GC/MS). The antifungal assays were performed against Candida strains through the broth microdilution method to determine the minimum fungicidal concentration (MFC). Fungal growth was assessed by optical density reading and the Candida albicans dimorphic effect was evaluated by optical microscopy in microculture chambers. The chemical profile of the essential oils identified 40 substances in the different collection periods with γ-terpinene being the predominant constituent. The antifungal activity revealed an action against the C. albicans , C. krusei and C. tropicalis strains with an IC
50 ranging from 345.5 to 2,754.2 µg/mL and a MFC higher than 1,024 µg/mL. When combined with essential oils at sub-inhibitory concentrations (MIC/16), fluconazole had its potentiated effect, i.e. a synergistic effect was observed in the combination of fluconazole with P.salutare oil against all Candida strains; however, for C. albicans , its effect was reinforced by the natural product in all the collection periods. The results show that the Psidium salutare oil affected the dimorphic transition capacity, significantly reducing the formation of hyphae and pseudohyphae in increasing concentrations. The results show that P. salutare oil exhibits a significant antifungal activity against three Candida species and that it can act in synergy with fluconazole. These results support the notion that this plant may have a potential use in pharmaceutical and preservative products., Competing Interests: The authors declare there are no competing interests.- Published
- 2018
- Full Text
- View/download PDF
36. Ethnobotany of the genus Taraxacum-Phytochemicals and antimicrobial activity.
- Author
-
Sharifi-Rad M, Roberts TH, Matthews KR, Bezerra CF, Morais-Braga MFB, Coutinho HDM, Sharopov F, Salehi B, Yousaf Z, Sharifi-Rad M, Del Mar Contreras M, Varoni EM, Verma DR, Iriti M, and Sharifi-Rad J
- Subjects
- Ethnobotany, Food Preservatives chemistry, Humans, Medicine, Traditional, Phytochemicals chemistry, Phytotherapy, Plant Extracts chemistry, Anti-Infective Agents pharmacology, Phytochemicals pharmacology, Plant Extracts pharmacology, Taraxacum chemistry
- Abstract
Plants belonging to the genus Taraxacum have been used in traditional healthcare to treat infectious diseases including food-borne infections. This review aims to summarize the available information on Taraxacum spp., focusing on plant cultivation, ethnomedicinal uses, bioactive phytochemicals, and antimicrobial properties. Phytochemicals present in Taraxacum spp. include sesquiterpene lactones, such as taraxacin, mongolicumin B, and taraxinic acid derivatives; triterpenoids, such as taraxasterol, taraxerol, and officinatrione; and phenolic derivatives, such as hydroxycinnamic acids (chlorogenic, chicoric, and caffeoyltartaric acids), coumarins (aesculin and cichoriin), lignans (mongolicumin A), and taraxacosides. Aqueous and organic extracts of different plant parts exhibit promising in vitro antimicrobial activity relevant for controlling fungi and Gram-positive and Gram-negative bacteria. Therefore, this genus represents a potential source of bioactive phytochemicals with broad-spectrum antimicrobial activity. However, so far, preclinical evidence for these activities has not been fully substantiated by clinical studies. Indeed, clinical evidence for the activity of Taraxacum bioactive compounds is still scant, at least for infectious diseases, and there is limited information on oral bioavailability, pharmacological activities, and safety of Taraxacum products in humans, though their traditional uses would suggest that these plants are safe., (© 2018 John Wiley & Sons, Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
37. Tagetes spp. Essential Oils and Other Extracts: Chemical Characterization and Biological Activity.
- Author
-
Salehi B, Valussi M, Morais-Braga MFB, Carneiro JNP, Leal ALAB, Coutinho HDM, Vitalini S, Kręgiel D, Antolak H, Sharifi-Rad M, Silva NCC, Yousaf Z, Martorell M, Iriti M, Carradori S, and Sharifi-Rad J
- Subjects
- Agriculture, Anti-Infective Agents chemistry, Anti-Infective Agents pharmacology, Food Additives, Food Preservatives, Medicine, Traditional, Phytochemicals chemistry, Phytochemicals pharmacology, Oils, Volatile chemistry, Oils, Volatile pharmacology, Plant Extracts chemistry, Plant Extracts pharmacology, Tagetes chemistry
- Abstract
Tagetes (marigold) is native to America, and its cultivation currently extends to other countries in Africa, Asia, and Europe. Many species of this genus, such as T. minuta , T. erecta , T. patula , and T. tenuifolia , are cultivated as ornamental plants and studied for their medicinal properties on the basis of their use in folk medicine. Different parts of the Tagetes species are used as remedies to treat various health problems, including dental, stomach, intestinal, emotional, and nervous disorders, as well as muscular pain, across the world. Furthermore, these plants are studied in the field of agriculture for their fungicidal, bactericidal, and insecticidal activities. The phytochemical composition of the extracts of different Tagetes species parts are reported in this work. These compounds exhibit antioxidant, antiinflammatory, and enzyme inhibitory properties. Cultivation and the factors affecting the chemical composition of Tagetes species are also covered. In the current work, available literature on Tagetes species in traditional medicine, their application as a food preservative, and their antimicrobial activities are reviewed.
- Published
- 2018
- Full Text
- View/download PDF
38. Matricaria genus as a source of antimicrobial agents: From farm to pharmacy and food applications.
- Author
-
Sharifi-Rad M, Nazaruk J, Polito L, Morais-Braga MFB, Rocha JE, Coutinho HDM, Salehi B, Tabanelli G, Montanari C, Del Mar Contreras M, Yousaf Z, Setzer WN, Verma DR, Martorell M, Sureda A, and Sharifi-Rad J
- Subjects
- Anti-Infective Agents pharmacology, Azulenes pharmacology, Bacterial Infections drug therapy, Coumarins metabolism, Farms, Flavonoids chemistry, Food, Food Industry, Food Preservatives, Hydroxybenzoates chemistry, Lactones pharmacology, Monocyclic Sesquiterpenes, Oils, Volatile pharmacology, Phytochemicals pharmacology, Plant Extracts pharmacology, Plant Oils chemistry, Seasons, Sesquiterpenes pharmacology, Sesquiterpenes, Guaiane, Anti-Infective Agents chemistry, Matricaria chemistry, Oils, Volatile chemistry, Phytochemicals chemistry, Plant Extracts chemistry, Plants, Medicinal chemistry
- Abstract
Matricaria is a widespread genus of flowering plants of the family Asteraceae that grow in temperate regions of Europe, Asia, America and Africa. Some of the species are also naturalized in Australia. Some species of this genus such as Chamomiles are recognized medicinal plants and cultivated in several countries for commercial purposes: to obtain its blue essence, as herbal tea, and for pharmaceutical or cosmeceutical uses. The phytochemical composition of Matricaria spp. includes volatile terpenoids (e.g., α-bisabolol, bisabolol oxide A and B, β-trans-farnesene and chamazulene), sesquiterpene lactones such as matricin, and phenolic compounds (flavonoids, coumarins and phenolic acids). Their essential oil is obtained from the fresh or dried inflorescences by steam distillation, and additionally cohobation of the remaining water. The volatile composition of the essential oil, especially the content of the valuable components α-bisabolol and chamazulene, depends on the plant part, origin and quality of the source, genetic, and environmental factors. Moreover, other parameters, such as season of harvest and methods of extraction, can affect the extraction yield of the essential oils/extracts, their composition and, therefore, their bioactivity. Due to the importance of this genus and particularly M. recutita (M. chamomilla), this review focus on its cultivation, factor affecting essential oils' composition and their role in traditional medicine, as antibacterial agents and finally as food preservatives., (Copyright © 2018 Elsevier GmbH. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
39. Chemical composition, antifungal activity and potential anti-virulence evaluation of the Eugenia uniflora essential oil against Candida spp.
- Author
-
Dos Santos JFS, Rocha JE, Bezerra CF, do Nascimento Silva MK, de Matos YMLS, de Freitas TS, Dos Santos ATL, da Cruz RP, Machado AJT, Rodrigues THS, de Brito ES, Sales DL, de Oliveira Almeida W, da Costa JGM, Coutinho HDM, and Morais-Braga MFB
- Subjects
- Antifungal Agents chemistry, Candida pathogenicity, Candida albicans drug effects, Fluconazole pharmacology, Gas Chromatography-Mass Spectrometry, Inhibitory Concentration 50, Microbial Sensitivity Tests, Oils, Volatile chemistry, Plant Oils chemistry, Plant Oils pharmacology, Antifungal Agents pharmacology, Candida drug effects, Eugenia chemistry, Oils, Volatile pharmacology
- Abstract
The development of fungal resistance to antifungal drugs has been worsening over the years and as a result research on new antifungal agents derived from plants has intensified. Eugenia uniflora L. (pitanga) has been studied for its various biological actions. In this study the chemical composition and antifungal effects of the E. uniflora essential oil (EULEO) were investigated against Candida albicans (CA), Candida krusei (CK) and Candida tropicalis (CT) standard strains. The essential oil obtained through hydro-distillation was analyzed by gas chromatography coupled to mass spectrometry (GC-MS). To determine the IC
50 of the oil, the cellular viability curve and the inhibitory effects were measured by means of the oil's association with Fluconazole in a broth microdilution assay with spectrophotometric readings. The Minimum Fungicidal Concentration (MFC) was determined by solid medium subculture with the aid of a guide plate while the assays used to verify morphological changes emerging from the action of the fractions were performed in microculture chambers at concentrations based on the microdilution. Two major oil constituents stand out from the chemical analysis: selina-1,3,7(11)-trien-8-one (36.37%) and selina-1,3,7(11)-trien-8-one epoxide (27.32%). The concentration that reduced microorganismal growth was ≥8,192 μg/mL while the IC50 varied, this being between 1892.47 and 12491.80 μg/mL (oil), 10.07 - 80.78 μg/mL (fluconazole) and 18.53 - 295.60 μg/mL (fluconazole + oil). The combined activity (fluconazole + oil) resulted in indifference and antagonism. A MFC of the oil in association with fluconazole was recorded at the concentration of 8,192 μg/mL against CA and CK. The oil caused the inhibition of CA and CT morphological transition. In view of the results obtained, additional research is needed to elucidate the activity of the E. uniflora oil over genetic and biochemical processes regarding its effect on Candida spp. virulence., (Copyright © 2018 Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
40. Analysis by UPLC-MS-QTOF and antifungal activity of guava (Psidium guajava L.).
- Author
-
Bezerra CF, Rocha JE, Nascimento Silva MKD, de Freitas TS, de Sousa AK, Dos Santos ATL, da Cruz RP, Ferreira MH, da Silva JCP, Machado AJT, Carneiro JNP, Sales DL, Coutinho HDM, Ribeiro PRV, de Brito ES, and Morais-Braga MFB
- Subjects
- Antifungal Agents chemistry, Candida drug effects, Molecular Structure, Plant Extracts chemistry, Psidium chemistry, Antifungal Agents pharmacology, Chromatography, Liquid methods, Mass Spectrometry methods, Plant Extracts pharmacology
- Abstract
Psidium guajava L. is a plant widely used for food and in folk medicine all over the world. Studies have shown that guava leaves have antifungal properties. In this study, Flavonoid and Tannic fractions were tested to investigate their chemical composition and antifungal potential in vitro.21 compounds in the two fractions, presenting a higher content of phenolic compounds. The antifungal assays were performed against Candida albicans, Candida tropicalis and Candida krusei by microdilution to determine the IC
50 and the cell viability curve. Minimal Fungicidal Concentration(MFC) and the inhibitory effects of the association of the fractions with Fluconazole, as well as the assays used to verify any morphological changes were performed in microculture chambers based on the concentrations from the microdilution. The IC50 of the isolated fractions and the fractions associated with each other were calculated, varying from 69.29 to 3444.62 μg/mL and the fractions associated with fluconazole varied from 925.56 to 1.57 μg/mL, it was clear that the association of the natural product with the antifungal presented a synergism. The fractions affected pleomorphism capacity and have a potential antifungal activity as they caused fungal inhibition in isolated use, potentiated the action of Fluconazole, reducing its concentration and impeding morphological transition, one of the virulence factors of the genus., (Copyright © 2018 Elsevier Ltd. All rights reserved.)- Published
- 2018
- Full Text
- View/download PDF
41. Antiparasitic effect of the Psidium guajava L. (guava) and Psidium brownianum MART. EX DC. (araçá-de-veado) extracts.
- Author
-
Machado AJT, Santos ATL, Martins GMAB, Cruz RP, Costa MDS, Campina FF, Freitas MA, Bezerra CF, Leal ALAB, Carneiro JNP, Coronel C, Rolón M, Gómez CV, Coutinho HDM, and Morais-Braga MFB
- Subjects
- Animals, Cell Line, Mice, Antiparasitic Agents pharmacology, Leishmania braziliensis drug effects, Leishmania infantum drug effects, Plant Extracts pharmacology, Plant Leaves chemistry, Psidium chemistry, Trypanosoma cruzi drug effects
- Abstract
In the search for new therapeutic agents against neglected diseases, both aqueous and hydroethanolic extracts from Psidium guajava L. and P. brownianum Mart ex DC leaves were investigated regarding their antiparasitic effect and cytotoxic potential. The extracts were tested at three concentrations (250, 500 and 1000 μg/mL) against Trypanosoma cruzi epimastigote forms (Chagas, 1909), Leishmania braziliensis (Vianna, 1911) and L. infantum promastigotes forms (Nicolle, 1908), as well as against fibroblasts. P. guajava showed no activity against T. cruzi forms, while the hydroethanolic (PBHE), aqueous by decoction (PBAED) and aqueous by infusion (PBAEI) P. browninaum extracts were responsible, respectively, for inhibiting 100, 100 and 92.68% of T. cruzi epimastigote growth at the 1000 μg/mL concentration. The P. brownianum hydroethanolic extract (PBHE) at the highest concentration caused 58.46% death in L. braziliensis, thus demonstrating moderate activity, however when tested against L. infantum, the PBHE inhibited their growth by 37.16%, revealing its low activity. As for the cytotoxicity assays, the P. brownianum aqueous extract by decoction (PBAED) obtained the highest death percentage when compared to the others, causing 90.85% fibroblast mortality at the 1000 μg/mL concentration., (Copyright © 2018 Elsevier Ltd. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
42. Echinacea plants as antioxidant and antibacterial agents: From traditional medicine to biotechnological applications.
- Author
-
Sharifi-Rad M, Mnayer D, Morais-Braga MFB, Carneiro JNP, Bezerra CF, Coutinho HDM, Salehi B, Martorell M, Del Mar Contreras M, Soltani-Nejad A, Uribe YAH, Yousaf Z, Iriti M, and Sharifi-Rad J
- Subjects
- Food Preservatives pharmacology, Humans, Medicine, Traditional, Oils, Volatile chemistry, Phytotherapy, Plants, Medicinal chemistry, Anti-Bacterial Agents pharmacology, Antioxidants pharmacology, Echinacea chemistry, Plant Extracts pharmacology
- Abstract
The genus Echinacea consists of 11 taxa of herbaceous and perennial flowering plants. In particular, Echinacea purpurea (L.) Moench is widely cultivated all over the United States, Canada, and in Europe, exclusively in Germany, for its beauty and reported medicinal properties. Echinacea extracts have been used traditionally as wound healing to improve the immune system and to treat respiratory symptoms caused by bacterial infections. Echinacea extracts have demonstrated antioxidant and antimicrobial activities, and to be safe. This survey aims at reviewing the medicinal properties of Echinacea species, their cultivation, chemical composition, and the potential uses of these plants as antioxidant and antibacterial agents in foods and in a clinical context. Moreover, the factors affecting the chemical composition of Echinacea spp. are also covered., (Copyright © 2018 John Wiley & Sons, Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
43. Inhibition of the TetK efflux-pump by the essential oil of Chenopodium ambrosioides L. and α-terpinene against Staphylococcus aureus IS-58.
- Author
-
Limaverde PW, Campina FF, da Cunha FAB, Crispim FD, Figueredo FG, Lima LF, Datiane de M Oliveira-Tintino C, de Matos YMLS, Morais-Braga MFB, Menezes IRA, Balbino VQ, Coutinho HDM, Siqueira-Júnior JP, Almeida JRGS, and Tintino SR
- Subjects
- Bacterial Proteins genetics, Bacterial Proteins metabolism, Cyclohexane Monoterpenes, Microbial Sensitivity Tests, Staphylococcus aureus genetics, Staphylococcus aureus metabolism, Anti-Bacterial Agents pharmacology, Bacterial Proteins antagonists & inhibitors, Chenopodium ambrosioides chemistry, Monoterpenes pharmacology, Oils, Volatile pharmacology, Plant Extracts pharmacology, Staphylococcus aureus drug effects
- Abstract
The use of natural products is crucial to suppress the development of these micro-organisms and to reduce the concentration necessary to inhibit these microrganisms, reducing the toxicity risks also. In this study, the essential oil from Chenopodium ambrosioides Leaves and its main constituent α-Terpinene were used in the antibacterial and potentiating activity of antibiotics and ethidium bromide assays, against the bacterial strains Staphylococcus aureus IS-58, carriers of efflux pumps. The Minimum Inhibitory Concentration (MIC) was determined using a microdilution method. The capacity of the aforementioned was also tested in combination with tetracycline and ethidium bromide, with the aim of improving the activity of the antibacterials. The MIC of the C. ambrosioides L. essential oil and of α-Terpinene were above 1024 μg/mL, comprising a clinically irrelevant value. However, when associated with the antibiotics, the C. ambrosioides L. essential oil, significantly decreased the MIC of tetracycline and ethidium bromide. The efflux pump is the only mechanism the bacteria possesses to reduce the toxicity of ethidium bromide, and thus this reduction in the MIC demonstrates that the C. ambrosioides L. essential oil is an effective option in the inhibition of the efflux pump present in these micro-organisms., (Copyright © 2017. Published by Elsevier Ltd.)
- Published
- 2017
- Full Text
- View/download PDF
44. Antibacterial, modulatory activity of antibiotics and toxicity from Rhinella jimi (Stevaux, 2002) (Anura: Bufonidae) glandular secretions.
- Author
-
Sales DL, Morais-Braga MFB, Santos ATLD, Machado AJT, Araujo Filho JA, Dias DQ, Cunha FABD, Saraiva RA, Menezes IRA, Coutinho HDM, Costa JGM, Ferreira FS, Alves RRDN, and Almeida WO
- Subjects
- Animals, Anti-Bacterial Agents toxicity, Artemia, Biological Products toxicity, Dose-Response Relationship, Drug, Drosophila melanogaster, Escherichia coli drug effects, Female, Male, Mice, Microbial Sensitivity Tests methods, Pseudomonas aeruginosa drug effects, Staphylococcus aureus drug effects, Anti-Bacterial Agents isolation & purification, Anti-Bacterial Agents pharmacology, Biological Products isolation & purification, Biological Products pharmacology, Bufonidae, Parotid Gland metabolism
- Abstract
The increase in microorganisms with resistance to medications has caused a strong preoccupation within the medical and scientific community. Animal toxins studies, such as parotoid glandular secretions from amphibians, possesses a great potential in the development of drugs, such as antimicrobials, as these possess bioactive compounds. It was evaluated Rhinella jimi (Stevaux, 2002) glandular secretions against standard and multi-resistant bacterial strains; the effect of secretions combined with drugs; and determined the toxicity using two biologic in vivo models, and a in vitro model with mice livers. Standard strains were used for the determination of the Minimum Inhibitory Concentration (MIC), while for the modulatory activity of antibiotics, the clinical isolates Escherichia coli 06, Pseudomonas aeruginosa 03 and Staphylococcus aureus 10 were used. Modulatory activity was evaluated by the broth microdilution method with aminoglycosides and β-lactams as target antibiotics. The secretions in association with the antibiotics have a significant reduction in MIC, both the aminoglycosides and β-lactams. The toxicity and cytotoxicity results were lower than the values used in the modulation. R. jimi glandular secretions demonstrated clinically relevant results regarding the modulation of the tested antimicrobials., (Copyright © 2017 Elsevier Masson SAS. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
45. Rhaphiodon echinus (Nees & Mart.) Schauer: Chemical, toxicological activity and increased antibiotic activity of antifungal drug activity and antibacterial.
- Author
-
Costa AR, de Lima Silva J, Lima KRR, Rocha MI, Barros LM, da Costa JGM, Boligon AA, Kamdem JP, Carneiro JNP, Leite NF, de Menezes IRA, Duarte AE, Morais-Braga MFB, and Coutinho HDM
- Subjects
- Animals, Anti-Bacterial Agents chemistry, Antifungal Agents chemistry, Artemia drug effects, Bacteria drug effects, Candida drug effects, Escherichia coli drug effects, Microbial Sensitivity Tests, Plant Extracts chemistry, Plant Leaves chemistry, Pseudomonas aeruginosa drug effects, Staphylococcus aureus drug effects, Anti-Bacterial Agents pharmacology, Antifungal Agents pharmacology, Plant Extracts pharmacology, Tracheophyta chemistry
- Abstract
The association of herbal products with standard antimicrobial drugs has recently gained more attention as a hope to overcome infectious diseases caused by multidrug-resistant microorganisms. Here, we investigated for the first time the antimicrobial (antifungal and antibacterial) activity of ethanolic and aqueous extracts of R. echinus against multiresistant strains of bacteria (E. coli, P. aeruginosa and S. aureus) and fungi (C. albicans, C. krusei and C. tropicalis), as well as potential to enhance the activity of antibiotics drugs. In addition, both extract were chemically characterized and their toxicity was assessed in Artemia salina. Our results demonstrate that aqueous extract of R. echinus caused a significant increase in the activity of antibiotics gentamicin and imipenem, while the ethanolic extract strongly enhanced the antibiotic activity of gentamicin, amikacin, imipenem and ciprofloxacin against P. aeruginosa. However, neither the ethanolic nor the aqueous extracts significantly affect the antibiotic activity of the drugs when tested against S. aureus. Phytochemical analysis of the extracts indicated ellagic acid, caffeic acid and chlorogenic acid as the major components which can be at least in part responsible for the enhanced activity of antibiotics. None of the extracts showed toxicity in A. salina even at the highest concentration tested (1000 μg/mL). All together, our results suggest that the leaf extract of R. echinus can be an effective source of modulating agents., (Copyright © 2017 Elsevier Ltd. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
46. Phytochemicals from fern species: potential for medicine applications.
- Author
-
Cao H, Chai TT, Wang X, Morais-Braga MFB, Yang JH, Wong FC, Wang R, Yao H, Cao J, Cornara L, Burlando B, Wang Y, Xiao J, and Coutinho HDM
- Abstract
Ferns are an important phytogenetic bridge between lower and higher plants. Historically they have been used in many ways by humans, including as ornamental plants, domestic utensils, foods, and in handicrafts. In addition, they have found uses as medicinal herbs. Ferns produce a wide array of secondary metabolites endowed with different bioactivities that could potentially be useful in the treatment of many diseases. However, there is currently relatively little information in the literature on the phytochemicals present in ferns and their pharmacological applications, and the most recent review of the literature on the occurrence, chemotaxonomy and physiological activity of fern secondary metabolites was published over 20 years ago, by Soeder (Bot Rev 51:442-536, 1985). Here, we provide an updated review of this field, covering recent findings concerning the bioactive phytochemicals and pharmacology of fern species., (© Springer Science+Business Media Dordrecht 2017.)
- Published
- 2017
- Full Text
- View/download PDF
47. Psidium guajava L. and Psidium brownianum Mart ex DC.: Chemical composition and anti - Candida effect in association with fluconazole.
- Author
-
Morais-Braga MFB, Sales DL, Carneiro JNP, Machado AJT, Dos Santos ATL, de Freitas MA, Martins GMAB, Leite NF, de Matos YMLS, Tintino SR, Souza DSL, Menezes IRA, Ribeiro-Filho J, Costa JGM, and Coutinho HDM
- Subjects
- Antifungal Agents isolation & purification, Chromatography, High Pressure Liquid, Inhibitory Concentration 50, Microbial Sensitivity Tests, Phytochemicals analysis, Plant Extracts isolation & purification, Spectrophotometry, Antifungal Agents pharmacology, Candida albicans drug effects, Candida tropicalis drug effects, Drug Synergism, Fluconazole pharmacology, Plant Extracts pharmacology, Psidium chemistry
- Abstract
The therapeutic combinations have been increasingly used against fungal resistance. Natural products have been evaluated in combination with pharmaceutical drugs in the search for new components able to work together in order to neutralize the multiple resistance mechanisms found in yeasts from the genus Candida. The aqueous and hydroethanolic extracts from Psidium brownianum Mart ex DC. and Psidium guajava L. species were evaluated for their potential to change the effect of commercial pharmaceutical drugs against Candida albicans and Candida tropicalis strains. The tests were performed according to the broth microdilution method. Plate readings were carried out by spectrophotometry, and the data generated the cell viability curve and IC50 of the extracts against the yeasts. A chemical analysis of all the extracts was performed for detection and characterization of the secondary metabolites. The total phenols were quantified in gallic acid eq/g of extract (GAE/g) and the phenolic composition of the extracts was determined by HPLC. Fluconazole and all extracts presented high Minimum Inhibitories Concentrations (MICs). However, when associated with the extracts at sub-inhibitory concentrations (MIC/16), fluconazole had its effect potentiated. A synergistic effect was observed in the combination of fluconazole with Psidium brownianum extracts against all Candida strains. However, for Psidium guajava extracts the synergistic effect was produced mainly against the Candida albicans LM77 and Candida tropicalis INCQS 400042 strains. The IC50 values of fluconazole ranged from 19.22 to 68.1 μg/mL when it was used alone, but from 2.2 to 45.4 μg/mL in the presence of the extracts. The qualitative chemical characterization demonstrated the presence of phenols, flavonoids and tannins among the secondary metabolites. The concentration of total phenols ranged from 49.25 to 80.77 GAE/g in the P. brownianum extracts and from 68.06 to 82.18 GAE/g in the P. guajava extracts. Our results indicated that both P. brownianum and P. guajava extracts are effective on potentiating the effect of fluconazole, and therefore, these plants have the potential for development of new effective drugs for treating fungal infections., (Copyright © 2016 Elsevier Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.